Is Surgery Partners Stock a Good Investment?
Surgery Partners Investment Advice | SGRY |
- Examine Surgery Partners' financial health by looking at its balance sheet, income statement, and cash flow statement. Analyze key financial ratios, such as Price-to-Earnings (P/E), Price-to-Sales (P/S), and Price-to-Book (P/B), to determine whether the stock is fairly valued or over/undervalued.
- Research Surgery Partners' leadership team and their track record. Good management can help Surgery Partners navigate difficult times and make strategic decisions that benefit shareholders and increases its net worth.
- Consider the overall health of the Health Care Providers & Services space and any emerging trends that could impact Surgery Partners' business and its evolving consumer preferences.
- Compare Surgery Partners' performance and market position to its competitors. Analyze how Surgery Partners is positioned in terms of product offerings, innovation, and market share.
- Check if Surgery Partners pays a dividend and its dividend yield and payout ratio.
- Review what financial analysts are saying about Surgery Partners' stock and their price targets. However, remember that analysts' opinions can vary, and their predictions may not always be accurate.
It's important to note that investing in Surgery Partners stock, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember that it's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. Below is a detailed guide on how to decide if Surgery Partners is a good investment.
Sell | Buy |
Strong Sell
Market Performance | Insignificant | Details | |
Volatility | Not too volatile | Details | |
Hype Condition | Under hyped | Details | |
Current Valuation | Undervalued | Details | |
Odds Of Distress | Below Average | Details | |
Economic Sensitivity | Moves slightly opposite to the market | Details | |
Investor Sentiment | Alarmed | Details | |
Analyst Consensus | Strong Buy | Details | |
Financial Strenth (F Score) | Poor | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
Examine Surgery Partners Stock
Researching Surgery Partners' stock involves analyzing various aspects of the company and its industry to make an informed investment decision. The key areas to focus on are fundamentals, business model and competitive advantage. It is also important to analyze trends in revenue, net income, and cash flow, as well as key financial ratios, such as price-to-earnings (P/E), price-to-sales (P/S), and debt-to-equity (D/E). About 98.0% of the company shares are owned by institutional investors. The company has price-to-book ratio of 1.71. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Surgery Partners has Price/Earnings To Growth (PEG) ratio of 1.66. The entity recorded a loss per share of 0.46. The firm had not issued any dividends in recent years.
To determine if Surgery Partners is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Surgery Partners' research are outlined below:
| Surgery Partners had very high historical volatility over the last 90 days | |
| The company reported the previous year's revenue of 2.74 B. Net Loss for the year was (11.9 M) with profit before overhead, payroll, taxes, and interest of 705.6 M. | |
| Surgery Partners has a poor financial position based on the latest SEC disclosures | |
| Over 98.0% of the company shares are owned by institutional investors | |
| Latest headline from finance.yahoo.com: MultiPlan Corporation Reports Q4 Loss, Misses Revenue Estimates |
Surgery Partners Quarterly Cash And Short Term Investments |
|
Surgery Partners uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in Surgery Partners. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Surgery Partners' previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 6th of March 2024 Upcoming Quarterly Report | View | |
| 6th of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 6th of March 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Earnings surprises can significantly impact Surgery Partners' stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate. Below are the table of largest EPS Surprises Surgery Partners' investors have experienced.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2016-05-05 | 2016-03-31 | 0.03 | 0.02 | -0.01 | 33 | ||
2022-08-02 | 2022-06-30 | -0.01 | -0.03 | -0.02 | 200 | ||
2020-03-05 | 2019-12-31 | 0.12 | 0.1 | -0.02 | 16 | ||
2016-08-09 | 2016-06-30 | 0.14 | 0.16 | 0.02 | 14 | ||
2024-05-07 | 2024-03-31 | 0.07 | 0.1 | 0.03 | 42 | ||
2023-11-07 | 2023-09-30 | 0.16 | 0.19 | 0.03 | 18 | ||
2022-05-03 | 2022-03-31 | -0.06 | -0.09 | -0.03 | 50 | ||
2017-05-09 | 2017-03-31 | 0.07 | 0.04 | -0.03 | 42 |
Know Surgery Partners' Top Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Surgery Partners is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Surgery Partners backward and forwards among themselves. Surgery Partners' institutional investor refers to the entity that pools money to purchase Surgery Partners' securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Geode Capital Management, Llc | 2024-12-31 | 1.9 M | Point72 Asset Management, L.p. | 2024-12-31 | 1.7 M | American Century Companies Inc | 2024-12-31 | 1.4 M | Goldman Sachs Group Inc | 2024-12-31 | 1.3 M | E Ohman J:or Asset Management Ab | 2024-12-31 | 1.2 M | Victory Capital Management Inc. | 2024-12-31 | 1.2 M | Hein Park Capital Management Lp | 2024-12-31 | 1.1 M | Silvercrest Asset Management Group Llc | 2024-12-31 | 998.5 K | Ubs Group Ag | 2024-12-31 | 990.2 K | Bain Capital Investors Llc | 2024-12-31 | 49.9 M | Fmr Inc | 2024-12-31 | 16.3 M |
Surgery Partners' market capitalization trends
The company currently falls under 'Mid-Cap' category with a current market capitalization of 3.23 B.Market Cap |
|
Surgery Partners' profitablity analysis
| Last Reported | Projected for Next Year | ||
| Return On Capital Employed | 0.06 | 0.07 | |
| Return On Equity | (0.01) | (0.01) |
Determining Surgery Partners' profitability involves analyzing its financial statements and using various financial metrics to determine if Surgery Partners is a good buy. For example, gross profit margin measures Surgery Partners' profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Surgery Partners' profitability and make more informed investment decisions.
Please note, the imprecision that can be found in Surgery Partners' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Surgery Partners. Check Surgery Partners' Beneish M Score to see the likelihood of Surgery Partners' management manipulating its earnings.
Evaluate Surgery Partners' management efficiency
Surgery Partners has return on total asset (ROA) of 0.039 % which means that it generated a profit of $0.039 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.0308 %, meaning that it created $0.0308 on every $100 dollars invested by stockholders. Surgery Partners' management efficiency ratios could be used to measure how well Surgery Partners manages its routine affairs as well as how well it operates its assets and liabilities. Return On Capital Employed is likely to rise to 0.07 in 2025, whereas Return On Tangible Assets are likely to drop (0) in 2025. At this time, Surgery Partners' Non Currrent Assets Other are fairly stable compared to the past year. Intangibles To Total Assets is likely to rise to 0.76 in 2025, whereas Total Assets are likely to drop slightly above 4.6 B in 2025.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 24.09 | 25.29 | |
| Tangible Book Value Per Share | (9.33) | (9.79) | |
| Enterprise Value Over EBITDA | 17.75 | 19.49 | |
| Price Book Value Ratio | 1.82 | 1.91 | |
| Enterprise Value Multiple | 17.75 | 19.49 | |
| Price Fair Value | 1.82 | 1.91 | |
| Enterprise Value | 2.5 B | 1.9 B |
The strategic initiatives led by Surgery Partners' management are central to its market success. By analyzing these initiatives, we provide a clear picture of the stock's growth prospects.
Beta 2.609 |
Basic technical analysis of Surgery Stock
As of the 27th of February, Surgery Partners has the Semi Deviation of 2.21, coefficient of variation of 1235.41, and Risk Adjusted Performance of 0.0675. In relation to fundamental indicators, the technical analysis model makes it possible for you to check existing technical drivers of Surgery Partners, as well as the relationship between them.Surgery Partners' insider trading activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Surgery Partners insiders, such as employees or executives, is commonly permitted as long as it does not rely on Surgery Partners' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Surgery Partners insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Surgery Partners' Outstanding Corporate Bonds
Surgery Partners issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Surgery Partners uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Surgery bonds can be classified according to their maturity, which is the date when Surgery Partners has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Dana 575 percent Corp BondUS235822AB96 | View | |
| MPLX LP 4125 Corp BondUS55336VAK61 | View | |
| MPLX LP 4875 Corp BondUS55336VAJ98 | View | |
| MPLX LP 52 Corp BondUS55336VAL45 | View | |
| BNP Paribas FRN Corp BondUSF1R15XK367 | View | |
| Morgan Stanley 3591 Corp BondUS61744YAK47 | View | |
| Morgan Stanley 3971 Corp BondUS61744YAL20 | View | |
| MGM Resorts International Corp BondUS552953CD18 | View |
Understand Surgery Partners' technical and predictive indicators
Using predictive indicators to make investment decisions involves analyzing Surgery Partners' various financial and market-based factors to help forecast future trends and identify investment opportunities. Select the indicators that are most relevant to your investment strategy. Each indicator has its own strengths and weaknesses, so it's essential to combine multiple indicators to get a more comprehensive view of the market and reduce the risk of making poor decisions based on limited data.
| Risk Adjusted Performance | 0.0675 | |||
| Market Risk Adjusted Performance | (0.38) | |||
| Mean Deviation | 2.19 | |||
| Semi Deviation | 2.21 | |||
| Downside Deviation | 2.38 | |||
| Coefficient Of Variation | 1235.41 | |||
| Standard Deviation | 3.61 | |||
| Variance | 13.03 | |||
| Information Ratio | 0.08 | |||
| Jensen Alpha | 0.2775 | |||
| Total Risk Alpha | 0.3139 | |||
| Sortino Ratio | 0.1215 | |||
| Treynor Ratio | (0.39) | |||
| Maximum Drawdown | 22.73 | |||
| Value At Risk | (3.57) | |||
| Potential Upside | 4.58 | |||
| Downside Variance | 5.65 | |||
| Semi Variance | 4.88 | |||
| Expected Short fall | (2.79) | |||
| Skewness | 3.08 | |||
| Kurtosis | 16.81 |
| Risk Adjusted Performance | 0.0675 | |||
| Market Risk Adjusted Performance | (0.38) | |||
| Mean Deviation | 2.19 | |||
| Semi Deviation | 2.21 | |||
| Downside Deviation | 2.38 | |||
| Coefficient Of Variation | 1235.41 | |||
| Standard Deviation | 3.61 | |||
| Variance | 13.03 | |||
| Information Ratio | 0.08 | |||
| Jensen Alpha | 0.2775 | |||
| Total Risk Alpha | 0.3139 | |||
| Sortino Ratio | 0.1215 | |||
| Treynor Ratio | (0.39) | |||
| Maximum Drawdown | 22.73 | |||
| Value At Risk | (3.57) | |||
| Potential Upside | 4.58 | |||
| Downside Variance | 5.65 | |||
| Semi Variance | 4.88 | |||
| Expected Short fall | (2.79) | |||
| Skewness | 3.08 | |||
| Kurtosis | 16.81 |
Consider Surgery Partners' intraday indicators
Surgery Partners intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Surgery Partners stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
| Accumulation Distribution | 0.0188 | |||
| Rate Of Daily Change | 1.0 | |||
| Day Median Price | 25.26 | |||
| Day Typical Price | 25.19 | |||
| Market Facilitation Index | 0.48 | |||
| Price Action Indicator | (0.21) | |||
| Relative Strength Index | 58.18 |
Surgery Partners Corporate Filings
| 12th of February 2025 Other Reports | ViewVerify | |
F4 | 4th of February 2025 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
| 30th of January 2025 Other Reports | ViewVerify | |
| 28th of January 2025 Other Reports | ViewVerify |
Surgery Stock media impact
Far too much social signal, news, headlines, and media speculation about Surgery Partners that are available to investors today. That information is available publicly through Surgery media outlets and privately through word of mouth or via Surgery internal channels. However, regardless of the origin, that massive amount of Surgery data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Surgery Partners news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Surgery Partners relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Surgery Partners' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Surgery Partners alpha.
Surgery Partners Sentiment by Major News Outlets
Investor sentiment, mood or attitude towards Surgery Partners can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Surgery Partners Corporate Executives
Elected by the shareholders, the Surgery Partners' board of directors comprises two types of representatives: Surgery Partners inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Surgery. The board's role is to monitor Surgery Partners' management team and ensure that shareholders' interests are well served. Surgery Partners' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Surgery Partners' outside directors are responsible for providing unbiased perspectives on the board's policies.
| David Doherty | Executive CFO | Profile | |
| David CPA | Executive CFO | Profile |
Additional Tools for Surgery Stock Analysis
When running Surgery Partners' price analysis, check to measure Surgery Partners' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Surgery Partners is operating at the current time. Most of Surgery Partners' value examination focuses on studying past and present price action to predict the probability of Surgery Partners' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Surgery Partners' price. Additionally, you may evaluate how the addition of Surgery Partners to your portfolios can decrease your overall portfolio volatility.